【摘要】 本研究观察小剂量抗胸腺细胞球蛋白(ATG)在对激素耐药的重度急性移植物抗宿主病(aGVHD)治疗中的作用。对6例单倍相合骨髓移植后出现激素耐药的重度aGVHD的患者给予小剂量ATG 1.25 mg/kg治疗,隔日1次,共3-5剂。结果显示, 完全缓解3例,其中2例无病生存,1例死于白血病复发;另3例中1例部分缓解,2例病情恶化,这3例患者均死于GVHD。应用小剂量ATG治疗的总有效率66.67%,长期生存率33.33%,感染是其主要并发症。结论:小剂量ATG对部分激素耐药的重度aGVHD有一定疗效,且无严重毒副作用,加强洁净环境保护以预防感染也颇为重要。
【关键词】 骨髓移植
Antithymocyte Globulin Used for Treatment of Severe Acute Graft Versus Host Disease after Haploidentical Bone Marrow Transplantation
Abstract The objective of study was to investigate the effect of lowdose antithymocyte globulin (ATG) on steroidresistant severe acute graft versus host disease (aGVHD). Six patients with steroidresistant severe aGVHD after haploidentical bone marrow transplantation (BMT) received the treatment with ATG at a low dose of 1.25 mg/kg for 3-5 doses every other day. The results showed that 3 out of 6 patients got completely remission (CR), among them 2 patients have still been in diseasefree survival, 1 patient died from leukemia relapse. 1 out of the other 3 patients got partial remissin (PR), 2 patients were aggravated. The other……
<<<<<全文未完,本文约2224个中文字,未计算英文字母、数字>>>>>